Abstract: Ablation systems and methods include an improved approach to generating heated vapor. The system includes a controller having a user interface and receives data indicative of a treatment time or desired energy level to be delivered during a treatment session, a pump in data communication with the controller, and a catheter having a bipolar electrode in fluid communication with the pump. The controller is configured to control a delivery of fluid and a generation of heated vapor based on the data indicative of the treatment time or desired level of energy to be delivered without modifying the flow rate of the fluid or the level of voltage and/or current of the electrical current based on data from sensors positioned in or on the catheter.

Abstract: Ablation catheters and systems include flexible catheter tips with at least one positioning element and ports for delivery of an ablative agent to a target tissue. The positioning element is used to define a treatment zone and position the catheter proximate the target tissue for ablation. Ablative fluid is delivered to the target tissue at subtherapeutic, therapeutic, or supratherapeutic doses over different time periods, with rest periods between each dose, to cause effective ablation of the target tissue.

Abstract: Ablation systems and methods include an improved approach to generating heated vapor. The vapor ablation system preferably has a controller having a user interface that receives data indicative of a time of a treatment session, a pump in data communication with the controller, and a catheter having an electrode and is in fluid communication with the pump. The controller is configured to control the pump to provide a fluid to the lumen of the catheter, cause an electrical current to be delivered to the electrode in order to heat the fluid in the lumen and convert the fluid to a heated vapor, control a delivery of the fluid and a generation of the heated vapor based on the data indicative of the time and without modifying the flow rate of the fluid or the level of voltage and/or current of the electrical current based on data from sensors positioned in or on the catheter.

Abstract: Systems and methods for diagnosing aircraft failure are provided. In one embodiment, a method can include receiving a first set of data from an aircraft in flight indicative of a failure event associated with the aircraft. The first set of data can be indicative of at least one or more conditions associated with the aircraft. The method can include performing one or more computer-based simulations to generate one or more simulated failure events, based at least in part on the conditions. The method can include identifying one or more simulated causes associated with the simulated failure events. The method can include determining one or more potential causes of at least a portion of the failure event, based at least in part on the simulated causes. The method can include communicating a second set of data indicative of at least the potential causes, to the aircraft while it is in flight.

Abstract: A device for delivering an occlusive element includes an elongate sheath having a lumen therein. An elongate core member is disposed within the lumen and is formed from a proximal portion and distal portion connected via a joint. The distal portion of the elongate member includes a severable junction secured to the occlusive element. A marker coil is coaxially arranged around the distal portion of the elongate core member and is partially disposed inside the sheath lumen. A coil member is coaxially arranged around the distal portion of the elongate core member and coaxially arranged around at least a portion of the marker coil extending outside the lumen of the sheath. The coil member is secured at a distal end thereof to the distal portion of the elongate core member. The device resists axial compression while allowing for radial bending.

Abstract: An implant assembly comprises an elongated pusher member, and an implantable device (e.g., a vaso-occlusive device) mounted to the distal end of the pusher member. The implant assembly further comprises an electrolytically severable joint disposed on the pusher member, wherein the implantable device detaches from the pusher member when the severable joint is severed, and a return electrode carried by the distal end of the pusher member (e.g., a coil disposed about the pusher member) in proximity to, but electrically isolated from, the severable joint. The implant assembly further comprises a terminal carried by the proximal end of the pusher member in electrical communication with the severable joint.

Abstract: An implant assembly comprises an elongated pusher member, and an implantable device (e.g., a vaso-occlusive device) mounted to the distal end of the pusher member. The implant assembly further comprises an electrolytically severable joint disposed on the pusher member, wherein the implantable device detaches from the pusher member when the severable joint is severed, and a return electrode carried by the distal end of the pusher member (e.g., a coil disposed about the pusher member) in proximity to, but electrically isolated from, the severable joint. The implant assembly further comprises a terminal carried by the proximal end of the pusher member in electrical communication with the severable joint.

Abstract: An implant assembly comprises an elongated pusher member, and an implantable device (e.g., a vaso-occlusive device) mounted to the distal end of the pusher member. The implant assembly further comprises an electrolytically severable joint disposed on the pusher member, wherein the implantable device detaches from the pusher member when the severable joint is severed, and a return electrode carried by the distal end of the pusher member (e.g., a coil disposed about the pusher member) in proximity to, but electrically isolated from, the severable joint. The implant assembly further comprises a terminal carried by the proximal end of the pusher member in electrical communication with the severable joint.

Abstract: The invention provides a system and method for achieving the cosmetically beneficial effects of shrinking collagen tissue in the dermis or other areas of tissue in an effective, non-invasive manner using an array of electrodes. Systems described herein allow for improved treatment of tissue. Additional variations of the system include array of electrodes configured to minimize the energy required to produce the desired effect.

Abstract: The invention provides a system and method for achieving the cosmetically beneficial effects of shrinking collagen tissue in the dermis or other areas of tissue in an effective, non-invasive manner using an array of electrodes. Systems described herein allow for improved treatment of tissue. Additional variations of the system include array of electrodes configured to minimize the energy required to produce the desired effect.

Abstract: An apparatus for delivering bone cement into a vertebra includes a cannula and a mix and delivery device pivotally coupled to the cannula. The mix and deliver provides a single device in which a flowable compound may be mixed and the dispensed into the vertebrae through the cannula. The mix and delivery device includes a piston, slidably disposed within a barrel of the device, for advancing the bone cement through an outlet communicating with the cannula. An actuating device, which exerts a pressure, is connected to an inlet on the mix and delivery device (either directly or through a tube). The pressure created by the actuating device is used to advance the piston within the mix and delivery device.

Abstract: The invention provides a system and method for achieving the cosmetically beneficial effects of shrinking collagen tissue in the dermis or other areas of tissue in an effective, non-invasive manner using an array of electrodes. Systems described herein allow for improved treatment of tissue. Additional variations of the system include array of electrodes configured to minimize the energy required to produce the desired effect.

Abstract: An apparatus for mixing and dispensing a multi-component compound. The device includes a tubular body with an internal chamber for mixing the multi-component compound. Disposed within and extending beyond the tubular body is a rod having a mixing disc located near a distal end. Also disposed within the tubular body is a moveable piston with a central opening through which the rod may pass.

Abstract: An implant assembly comprises an elongated pusher member, and an implantable device (e.g., a vaso-occlusive device) mounted to the distal end of the pusher member. The implant assembly further comprises an electrolytically severable joint disposed on the pusher member, wherein the implantable device detaches from the pusher member when the severable joint is severed, and a return electrode carried by the distal end of the pusher member (e.g., a coil disposed about the pusher member) in proximity to, but electrically isolated from, the severable joint. The implant assembly further comprises a terminal carried by the proximal end of the pusher member in electrical communication with the severable joint.

Abstract: An apparatus for delivering bone cement into a vertebra, includes a cannula, a delivery device in communication with the cannula and a pressure delivery device in communication with the delivery device. The pressure delivery device provides an actuating force that acts either directly or through a medium to cause a flowable compound to be delivered from the delivery device to the cannula and into the vertebra. The pressure delivery device causes a pressurized compound to be delivered, the pressurized compound may be liquid or gaseous CO2 or other mediums.

Abstract: A vehicular frame assembly upon which a body portion and other components of a vehicle can be mounted is manufactured by initially casting a node that includes a body portion having a plurality of mounting portions. A first structural member is secured to each of the mounting portions of the node. Second structural members are secured to the first structural members to form a vehicular frame assembly upon which a body portion and other components of a vehicle can be mounted. If desired, a plurality of nodes is initially cast that each include a body portion having a plurality of mounting portions. A plurality of structural members is secured to the plurality of nodes to form the vehicular frame assembly.

Abstract: The invention provides a system and method for achieving the cosmetically beneficial effects of shrinking collagen tissue in the dermis or other areas of tissue in an effective, non-invasive manner using an array of electrodes. Systems described herein allow for improved treatment of tissue. Additional variations of the system include array of electrodes configured to minimize the energy required to produce the desired effect.

Abstract: The invention provides a system and method for achieving the cosmetically beneficial effects of shrinking collagen tissue in the dermis or other areas of tissue in an effective, non-invasive manner using an array of electrodes. Systems described herein allow for improved treatment of tissue. Additional variations of the system include array of electrodes configured to minimize the energy required to produce the desired effect.

Abstract: An implant system places magnetic structures in or on tissue that develop a magnetic repelling force between a soft palate a posterior pharyngeal wall. The magnetic repelling force has a magnitude F-mag, where F-mag=f (F-sep, F-nat), and where F-sep is a force required to separate soft palate tissue from pharyngeal wall tissue during sleep, and F-nat is a force exerted by native muscle on the soft palate during swallowing and/or drinking and/or speech. In another embodiment, a palate implant uses attractive magnetic force to keep the airway open.

Abstract: Systems and methods resist posterior movement of both the tongue and the soft palate/uvula during sleep, thereby keeping an airway open. The systems and methods employ first, second, and third structures. The first structure is sized and configured for placement in or on a tongue. The second structure is sized and configured for placement in or on a region of a soft palate or uvula. The third structure is sized and configured for placement in or on tissue in a desired relationship. anterior of the first and second structures. The first and second structures each includes a ferromagnetic material. The third structure includes a magnetic material that magnetically interacts with both the first and second ferromagnetic materials by attracting both the first and second ferromagnetic materials, thereby resisting posterior movement of both the tongue and the soft palate/uvula.